Definigen
OverviewSuggest Edit
Definigen is a company that provides functional disease model human cells, including hepatocytes, pancreatic beta cells, and intestinal organoids. It develops OptiDIFF, a platform technology that focuses on induced pluripotent stem cell (iPSC) generation, CRISPR-Cas9 gene editing, iPSC differentiation, and custom disease model development. The company delivers its services across life science, drug discovery, and regenerative medicine sectors.
| Type | Private | |
| Founded | 2012 | |
| HQ | Babraham, GB | Map |
| Website | definigen.com |
Locations
Latest Updates
| Employees (est.) (Feb 2020) | 14 |
Definigen Office Locations
Definigen has an office in Babraham
Babraham, GB (HQ)
Babraham Research Campus Moneta Building B280
Definigen Financials and Metrics
Summary Metrics
Founding Date | 2012 |
Definigen Online and Social Media Presence
Definigen's Trends
Twitter Engagement Stats for @definigen
181
Tweets
176
Following
1.1k
Followers
1
Tweets last 30 days
1
Avg. likes per Tweet
100%
Tweets with engagement
Definigen Frequently Asked Questions
When was Definigen founded?
Definigen was founded in 2012.
How many employees does Definigen have?
Definigen has 14 employees.
Who are Definigen competitors?
Competitors of Definigen include Nuclera, Pencil Biosciences and BlueRock Therapeutics.
Where is Definigen headquarters?
Definigen headquarters is located at Babraham Research Campus Moneta Building B280, Babraham.
Where are Definigen offices?
Definigen has an office in Babraham.
How many offices does Definigen have?
Definigen has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies